Dr. Dattatray Pawar is a seasoned medical affairs leader at Alkem Laboratories Limited, where he heads the medical affairs function with a relentless commitment to bridging science and patient-centric pharmaceutical innovation. With a foundational academic grounding in pharmacology (MD in Pharmacology), his career blends rigorous clinical insight with strategic industry experience, having previously contributed in major healthcare settings, including roles at Abbott and Sun Pharmaceuticals, before joining Alkem.

In his role as Head of Medical Affairs, Dr. Pawar drives the scientific narrative for Alkem’s diversified portfolio, ensuring that evidence-based medicine underpins product positioning, lifecycle strategy, and engagement with the medical community. His leadership encompasses scientific communications, real-world evidence generation, clinical study oversight, and cross-functional collaboration to inform both internal strategy and external physician engagement. This role is pivotal in strengthening Alkem’s reputation as a partner to healthcare professionals and in enhancing patient outcomes across therapeutic areas.

Dr. Pawar’s contributions extend into published research and collaborative clinical studies, where he has co-authored peer-reviewed papers spanning infectious diseases, antibiotic efficacy, and safety research—work that underscores his commitment to advancing meaningful clinical knowledge and supporting evidence-driven treatment decisions across India’s evolving healthcare landscape.

Beyond traditional medical affairs responsibilities, he has also been recognized within professional networks for his influence in healthcare discourse, including being identified among the Top 50 Influential Doctors on Social Media in India, reflecting his engagement with broader scientific and physician communities and his role in shaping informed dialogue around medical science and patient care.

Dr. Pawar’s career reflects a rare synthesis of clinical acumen, scientific authorship, strategic leadership, and commitment to elevating medical understanding—making him a key architect of how medical insights translate into impactful healthcare solutions at one of India’s leading pharmaceutical innovators.